Thermo Fisher Scientific Inc (TMO)
580.05
-4.10
(-0.70%)
USD |
NYSE |
Mar 18, 16:00
581.00
+0.95
(+0.16%)
Pre-Market: 20:00
Thermo Fisher Scientific Debt to Equity Ratio: 0.7471 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 0.7471 |
September 30, 2023 | 0.7784 |
June 30, 2023 | 0.7773 |
March 31, 2023 | 0.8343 |
December 31, 2022 | 0.7842 |
September 30, 2022 | 0.6696 |
June 30, 2022 | 0.7155 |
March 31, 2022 | 0.812 |
December 31, 2021 | 0.8548 |
September 30, 2021 | 0.5608 |
June 30, 2021 | 0.5095 |
March 31, 2021 | 0.5318 |
December 31, 2020 | 0.6299 |
September 30, 2020 | 0.6628 |
June 30, 2020 | 0.7134 |
March 31, 2020 | 0.6992 |
December 31, 2019 | 0.5982 |
September 30, 2019 | 0.5809 |
June 30, 2019 | 0.6627 |
March 31, 2019 | 0.6553 |
December 31, 2018 | 0.6884 |
September 30, 2018 | 0.6982 |
June 30, 2018 | 0.7344 |
March 31, 2018 | 0.8014 |
December 31, 2017 | 0.8267 |
Date | Value |
---|---|
September 30, 2017 | 0.8903 |
June 30, 2017 | 0.7501 |
March 31, 2017 | 0.7832 |
December 31, 2016 | 0.7719 |
September 30, 2016 | 0.8732 |
June 30, 2016 | 0.6653 |
March 31, 2016 | 0.7186 |
December 31, 2015 | 0.5842 |
September 30, 2015 | 0.6385 |
June 30, 2015 | 0.6781 |
March 31, 2015 | 0.746 |
December 31, 2014 | 0.7088 |
September 30, 2014 | 0.7058 |
June 30, 2014 | 0.754 |
March 31, 2014 | 0.8498 |
December 31, 2013 | 0.6222 |
September 30, 2013 | 0.4326 |
June 30, 2013 | 0.4502 |
March 31, 2013 | 0.4563 |
December 31, 2012 | 0.4607 |
September 30, 2012 | 0.4887 |
June 30, 2012 | 0.4327 |
March 31, 2012 | 0.4366 |
December 31, 2011 | 0.4673 |
September 30, 2011 | 0.4695 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.5095
Minimum
Jun 2021
0.8548
Maximum
Dec 2021
0.6889
Average
0.6844
Median
Debt to Equity Ratio Benchmarks
Fonar Corp | 0.0008 |
XWELL Inc | 0.00 |
ProPhase Labs Inc | 0.1294 |
Applied DNA Sciences Inc | 0.00 |
OncoCyte Corp | 0.00 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 98.73B |
Total Liabilities (Quarterly) | 51.88B |
Shareholders Equity (Quarterly) | 46.74B |
Current Ratio | 1.755 |
Net Debt Paydown Yield | -0.56% |